Trial record 15 of 46 for:    "Adrenocortical carcinoma"

German Adrenocortical Carcinoma Registry

The recruitment status of this study is unknown because the information has not been verified recently.
Verified July 2010 by University of Wuerzburg.
Recruitment status was  Recruiting
Sponsor:
Collaborator:
Deutsche Krebshilfe e.V., Bonn (Germany)
Information provided by:
University of Wuerzburg
ClinicalTrials.gov Identifier:
NCT00453674
First received: March 28, 2007
Last updated: July 7, 2010
Last verified: July 2010
  Purpose

Basic objective of the German Adrenocortical Carcinoma Registry is to improve the care of patients with adrenocortical cancer. The registration of as many patients as possible helps to collect data for the prognosis and prospects of success regarding different treatment plans. This data will be taken into consideration for planning prospective studies. With this registry, the recruitment of patients for prospective studies will be significantly facilitated. In this way - and in cooperation with networks in other countries (e.g. in Italy and France) - a structure allowing systematic improvement of therapy will be developed.


Condition
Adrenocortical Carcinoma

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Deutsches Nebennieren-Karzinom-Register - German Adrenocortical Carcinoma Registry

Resource links provided by NLM:


Further study details as provided by University of Wuerzburg:

Estimated Enrollment: 1000
Study Start Date: January 2003
Estimated Study Completion Date: December 2012
Groups/Cohorts
Adrenocortical carcinoma
Adrenocortical carcinoma

  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Adrenocortical carcinoma patients in Germany (or treated in Germany)

Criteria

Inclusion Criteria:

  • Histologically confirmed diagnosis of adrenocortical carcinoma
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00453674

Contacts
Contact: Martin Fassnacht, MD 49-931-201-36507 fassnacht_m@medizin.uni-wuerzburg.de
Contact: Bruno Allolio, MD allolio_b@medizin.uni-wuerzburg.de

Locations
Germany
University of Wuerzburg Recruiting
Wuerzburg, Germany, 97080
Contact: Martin Fassnacht, MD       fassnacht_m@medizin.uni-wuerzburg.de   
Sponsors and Collaborators
University of Wuerzburg
Deutsche Krebshilfe e.V., Bonn (Germany)
Investigators
Principal Investigator: Bruno Allolio, MD University of Wuerzburg
  More Information

Additional Information:
No publications provided

ClinicalTrials.gov Identifier: NCT00453674     History of Changes
Other Study ID Numbers: Wue-ACC-R-86-03
Study First Received: March 28, 2007
Last Updated: July 7, 2010
Health Authority: Germany: Ethics Commission

Keywords provided by University of Wuerzburg:
Adrenal cancer
Treatment
Surgery
Mitotane

Additional relevant MeSH terms:
Adrenocortical Carcinoma
Carcinoma
Neoplasms, Glandular and Epithelial
Neoplasms by Histologic Type
Neoplasms
Adenocarcinoma
Adrenal Cortex Neoplasms
Adrenal Gland Neoplasms
Endocrine Gland Neoplasms
Neoplasms by Site
Adrenal Cortex Diseases
Adrenal Gland Diseases
Endocrine System Diseases

ClinicalTrials.gov processed this record on August 01, 2014